Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

VRTX | NASDAQ
Chart Builder DCF Calculator
$537.79
-$0.81 (-0.15%)
At close: Nov 16, 2026, 4:00 PM ET
$538.10
+$0.31 (+0.06%)
After-hours: Nov 16, 2026, 7:34 PM ET
-0.15%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
53.6
+1.0 pts
Fundamentals Strong
Market Sentiment Neutral
Moat Wide
Sector Rank #209/1021 (Top 20%)

Why Price Moved

11 days ago
-1.93%

Shares are trading lower after Q3 earnings missed ...

Key Statistics

Market Data

Market Cap $136.35B
1D Range
534.12 549.56
52W Range
421.03 558.88

Valuation (TTM)

PE 34.61
PB 6.52
EV/EBITDA 27.49

Valuation (NTM)

Forward PE 29.66
Forward PEG -19.73
Price Target $608.00
Loading financial charts...

Profile

Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The ...

Sector Healthcare
Industry Biotechnology
Employees 6,400
IPO Date Jul 24, 1991
Fiscal Year January - December

Latest News

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Biopharma Conference 2026 Transcript

17 hours ago · seekingalpha.com

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Biopharma Conference 2026 Transcript
Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

5 days ago · zacks.com

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
VRTX's Q3 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised

14 days ago · zacks.com

VRTX's Q3 Earnings Lag Estimates, Revenues Top, 2026 Sales View Raised
Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call Transcript

14 days ago · seekingalpha.com

Vertex Pharmaceuticals Incorporated (VRTX) Q3 2026 Earnings Call Transcript
Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

14 days ago · zacks.com

Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Vertex Pharmaceuticals (VRTX) Misses Q3 Earnings Estimates

14 days ago · zacks.com

Vertex Pharmaceuticals (VRTX) Misses Q3 Earnings Estimates
Ahead of Vertex (VRTX) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics

20 days ago · zacks.com

Ahead of Vertex (VRTX) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

20 days ago · zacks.com

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why

21 days ago · zacks.com

Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

22 days ago · zacks.com

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Earnings

Latest Earnings
Nov 2, 2026
EPS
$4.76
Miss -1.24%
REV
$3.44B
Beat +0.62%
Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
24
Consensus
Buy
Price Target
$608.00
Upside
+13.06%
Buy (21)
Hold (2)
Sell (1)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.